Key Takeaways
- • Global Healthcare Opportunities and CBC Group are merging to create a $21 billion healthcare-focused investment platform, positioning it as the largest healthcare-specialized investment manager globally by assets under management.
- • The combined entity will operate across 13 global offices spanning North America, Europe, and Asia-Pacific, consolidating geographic reach and access to major healthcare R&D hubs to accelerate deal flow and portfolio deployment.
- • Mike Mortimer (GHO co-founder) and Fu Wei (CBC Group co-founder) will serve as co-chief executives of the merged platform, with transaction completion expected in early 2027 subject to regulatory approvals.
- • Existing funds and portfolio companies will maintain independent management under current investment teams, with no changes to fund-level investment mandates, governance structures, or ownership arrangements.
- • The merger exemplifies broader consolidation trends among specialist healthcare investment managers seeking scale, deeper healthcare company relationships, and expanded private markets capabilities in life sciences, pharmaceuticals, and medical technology.
Summary
Global Healthcare Opportunities (GHO) and CBC Group have agreed to merge their healthcare investment operations, creating a combined platform with more than $21 billion in assets under management. According to the joint statement from both firms, the enlarged entity will become the largest healthcare-focused investment manager globally by assets, marking a significant consolidation in the specialist healthcare investment sector.
The merged platform will maintain operations across 13 global offices spanning North America, Europe, and Asia-Pacific—regions that collectively represent the majority of worldwide healthcare research and development activity. This geographic footprint positions the combined business to deepen relationships with healthcare companies and accelerate capital deployment across private markets spanning life sciences, pharmaceuticals, and medical technology sectors.
Leadership structure reflects a partnership model: GHO co-founder Mike Mortimer and CBC Group co-founder Fu Wei will jointly serve as co-chief executives upon transaction completion. The firms have confirmed that the merger will preserve operational independence at the fund level, with existing funds and portfolio companies continuing to be managed by their current investment teams under unchanged mandates, governance structures, and ownership arrangements.
The transaction is expected to close in early 2027, subject to customary regulatory approvals and closing conditions. Both firms emphasize that the combination reflects a growing industry trend of consolidation among specialist healthcare investment managers, who are increasingly seeking to scale capabilities, broaden geographic reach, and improve access to deal flow across key innovation hubs. The expanded platform is positioned to leverage its combined footprint and resources to accelerate private markets deployment in healthcare-focused investments.
The merged platform will maintain operations across 13 global offices spanning North America, Europe, and Asia-Pacific—regions that collectively represent the majority of worldwide healthcare research and development activity. This geographic footprint positions the combined business to deepen relationships with healthcare companies and accelerate capital deployment across private markets spanning life sciences, pharmaceuticals, and medical technology sectors.
Leadership structure reflects a partnership model: GHO co-founder Mike Mortimer and CBC Group co-founder Fu Wei will jointly serve as co-chief executives upon transaction completion. The firms have confirmed that the merger will preserve operational independence at the fund level, with existing funds and portfolio companies continuing to be managed by their current investment teams under unchanged mandates, governance structures, and ownership arrangements.
The transaction is expected to close in early 2027, subject to customary regulatory approvals and closing conditions. Both firms emphasize that the combination reflects a growing industry trend of consolidation among specialist healthcare investment managers, who are increasingly seeking to scale capabilities, broaden geographic reach, and improve access to deal flow across key innovation hubs. The expanded platform is positioned to leverage its combined footprint and resources to accelerate private markets deployment in healthcare-focused investments.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.